Insider · CIK 0001746541

Reed Joshua

Reports to the SEC for 4 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001746541

Forms 4 and 5

Insider transactions

35 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-08	ALKSAlkermes plc.M Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	+9,164 sh	—	—	9,164
2026-10-08	ALKSAlkermes plc.F Tax Payment	SVP, Chief Financial Officer	FTax Payment	−4,069 sh	$40.11	−$163K	5,095
2026-10-08	ALKSAlkermes plc. · Restricted Stock Unit AwardM Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	−9,164 sh	—	—	27,492
2026-07-01	SRRKScholar Rock Holding CorpS Sale	Director	SSale	−2,105 sh	$53.50	−$113K	20,466
2026-07-01	SRRKScholar Rock Holding CorpS Sale	Director	SSale	−948 sh	$54.28	−$51.5K	19,518
2026-06-04	SRRKScholar Rock Holding CorpA Award	Director	AAward	+6,839 sh	—	—	22,571
2026-06-04	SRRKScholar Rock Holding Corp · Stock Option (Right to Buy)A Award	Director	AAward	+4,310 sh	—	—	4,310
2026-03-02	ALKSAlkermes plc. · Employee Stock Option (Right to Buy)A Award	SVP, Chief Financial Officer	AAward	+66.4K sh	—	—	66,430
2026-03-02	ALKSAlkermes plc. · Restricted Stock Unit AwardA Award	SVP, Chief Financial Officer	AAward	+30.9K sh	—	—	30,854
2025-10-08	ALKSAlkermes plc. · Employee Stock Option (Right to Buy)A Award	SVP, Chief Financial Officer	AAward	+159K sh	—	—	158,743
2025-10-08	ALKSAlkermes plc. · Restricted Stock Unit AwardA Award	SVP, Chief Financial Officer	AAward	+36.7K sh	—	—	36,656
2025-05-29	SRRKScholar Rock Holding CorpS Sale	Director	SSale	−4,900 sh	$29.68	−$145K	16,232
2025-05-29	SRRKScholar Rock Holding CorpS Sale	Director	SSale	−500 sh	$30.04	−$15K	15,732
2025-05-22	SRRKScholar Rock Holding CorpA Award	Director	AAward	+7,632 sh	—	—	21,132
2025-05-22	SRRKScholar Rock Holding Corp · Stock Option (Right to Buy)A Award	Director	AAward	+9,206 sh	—	—	9,206
2024-06-27	SRRKScholar Rock Holding CorpA Award	Director	AAward	+13.5K sh	—	—	13,500
2024-06-27	SRRKScholar Rock Holding Corp · Stock Option (Right to Buy)A Award	Director	AAward	+18K sh	—	—	18,000
2024-02-07	Omega Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+110K sh	—	—	110,000
2023-06-21	SRRKScholar Rock Holding Corp · Stock Option (Right to Buy)A Award	Director	AAward	+36K sh	—	—	36,000
2023-02-28	Omega Therapeutics, Inc.Option (Right to Buy)A Award	Chief Financial Officer	AAward	+55K sh	—	—	55,000
2022-10-27	Omega Therapeutics, Inc.Option (Right to Buy)A Award	Chief Financial Officer	AAward	+55K sh	—	—	55,000
2022-05-31	Omega Therapeutics, Inc.Option (Right to Buy)A Award	Chief Financial Officer	AAward	+320K sh	—	—	320,000
2022-05-26	SRRKScholar Rock Holding Corp · Stock Option (Right to Buy)A Award	Director	AAward	+28K sh	—	—	28,000
2022-03-30	ALDXAldeyra Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+93.3K sh	—	—	274,825
2022-03-30	ALDXAldeyra Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+250K sh	—	—	250,000
2021-04-12	ALDXAldeyra Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+150K sh	—	—	150,185
2021-03-16	SRRKScholar Rock Holding Corp · Stock Options (Right to Buy)A Award	Director	AAward	+15.6K sh	—	—	15,600
2020-03-02	ALDXAldeyra Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+250K sh	—	—	285,774
2020-03-02	ALDXAldeyra Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+138K sh	—	—	137,707
2020-03-02	ALDXAldeyra Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+138K sh	—	—	173,481
2020-03-02	ALDXAldeyra Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+250K sh	—	—	250,000
2019-09-05	ALDXAldeyra Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+3,200 sh	$4.71	+$15.1K	35,774
2019-03-05	ALDXAldeyra Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+29.6K sh	—	—	29,637
2019-03-05	ALDXAldeyra Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+250K sh	—	—	250,000
2018-07-30	ALDXAldeyra Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+75K sh	—	—	75,000

Recent filings

Accepted (ET)
Oct 94
Reed Joshua0001520262-26-000131
SEC(opens sec.gov)
Jul 64
Reed Joshua0001193125-26-296247
SEC(opens sec.gov)
Jun 84
Reed Joshua0001104659-26-071430
SEC(opens sec.gov)
Mar 44
Reed Joshua0001520262-26-000063
SEC(opens sec.gov)
Oct 104
Reed Joshua0001520262-25-000006
SEC(opens sec.gov)
May 304
Reed Joshua0001415889-25-015002
SEC(opens sec.gov)
May 234
Reed Joshua0001104659-25-052482
SEC(opens sec.gov)
Jul 14
Reed Joshua0001415889-24-018647
SEC(opens sec.gov)
Feb 94
Reed Joshua0000950170-24-013352
SEC(opens sec.gov)
Jun 224
Reed Joshua0001415889-23-010205
SEC(opens sec.gov)
Mar 24
Reed Joshua0000899243-23-006726
SEC(opens sec.gov)

Companies

Address

900 WINTER STREET

WALTHAM, MA, 02451